| Literature DB >> 29309623 |
Toru Atsumi1, Hironao Suzuki1, Jing-Jing Jiang1, Yuko Okuyama2, Ikuma Nakagawa1, Mitsutoshi Ota1, Yuki Tanaka1, Takuto Ohki1, Kokichi Katsunuma1, Koichi Nakajima3, Yoshinori Hasegawa4, Osamu Ohara4,5, Hideki Ogura1, Yasunobu Arima1, Daisuke Kamimura1, Masaaki Murakami1.
Abstract
RNA-binding motif 10 (Rbm10) is an RNA-binding protein that regulates alternative splicing, but its role in inflammation is not well defined. Here, we show that Rbm10 controls appropriate splicing of DNA (cytosine-5)-methyltransferase 3b (Dnmt3b), a DNA methyltransferase, to regulate the activity of NF-κB-responsive promoters and consequently inflammation development. Rbm10 deficiency suppressed NF-κB-mediated responses in vivo and in vitro. Mechanistic analysis showed that Rbm10 deficiency decreased promoter recruitment of NF-κB, with increased DNA methylation of the promoter regions in NF-κB-responsive genes. Consistently, Rbm10 deficiency increased the expression level of Dnmt3b2, which has enzyme activity, while it decreased the splicing isoform Dnmt3b3, which does not. These two isoforms associated with NF-κB efficiently, and overexpression of enzymatically active Dnmt3b2 suppressed the expression of NF-κB targets, indicating that Rbm10-mediated Dnmt3b2 regulation is important for the induction of NF-κB-mediated transcription. Therefore, Rbm10-dependent Dnmt3b regulation is a possible therapeutic target for various inflammatory diseases. © The Japanese Society for Immunology. 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: NF-κB; RNA splicing; chemokines; cytokines
Mesh:
Substances:
Year: 2017 PMID: 29309623 DOI: 10.1093/intimm/dxx067
Source DB: PubMed Journal: Int Immunol ISSN: 0953-8178 Impact factor: 4.823